Donald TrumpГудков, Андрей ВладимировичDhyan ChandraKevin H EngDominic J. SmiragliaHemn MohammadpourCurt D. SigmundKazuaki TakabeBinnian WeiAbdul Hamid AlraiyesDingxiao ZhangChristine E ShefferChristine BrunLajos P. BaloghSubhamoy DasguptaKate Rittenhouse-OlsonBoyko S AtanassovSwaminathan PadmanabhanAustin MillerGregory M LoewenZhuo XingMichael E FeiginKathleen M KokolusSaby GeorgeDheerendra PrasadPéter RapaliPhilip L McCarthyGeorge L ChenLori ShepherdJia FangYuesheng ZhangSong YaoTsukasa ShigehiroScott H OlejniczakYoungnim ChoiHenry G WithersMartin MorganRupesh K SrivastavaLesleyAnn HawthornSarah A Holstein
P108
A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate CancerPorfimer Sodium Interstitial Photodynamic Therapy With or Without Standard of Care Chemotherapy in Treating Patients With Locally Advanced or Recurrent Head and Neck CancerS1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder CancerLung-MAP: Durvalumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching BiomarkersPhase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal CancerCT Antigen TCR-redirected T Cells for Ovarian Cancer.A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic CancerNivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal CancerPegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerCombination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch RepairCombination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal CancerAtezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical CancerDoxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryVaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in SurgeryPhase I/II Study of hLL1 in Multiple MyelomaVaccine Therapy Before Surgery in Treating Patients With Localized Kidney CancerSVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance TherapyPomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple MyelomaEntinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney CancerSitravatinib and Nivolumab in Urothelial Carcinoma StudyLow GI Diet in Children and Adolescents With ALLKX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to TreatmentStudy of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial CancerPhase II Study of Forodesine in Subjects With Chronic Lymphocytic Leukemia (CLL)A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic CancerSafety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) TherapyS0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic LeukemiaSe-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy PatientsSunitinib in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaDonor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other DiseasesS0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung CancerEfficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Accelerated Phase or Blast Phase (Blast Crisis)A Phase I Study of BMS-690514 in Combination With Paclitaxel and CarboplatinA Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic LeukemiaLevonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian CancerCombination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid LeukemiaCombination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic SyndromesBevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical CancerA Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
P6153
Q27947481-f78a0075-41b4-1c68-c703-d557a694346dQ30880170-B413D6D3-9754-4B2B-9612-C614A6EB1B35Q37377517-1B21B1E0-C31C-4B7B-851E-589212017542Q38801320-4D42263E-0226-4C8B-A265-63B14945D90BQ38803257-B811964E-F230-4973-BC76-A76AF2BDC471Q40094046-DD6448EF-EAA7-4E5E-B468-980D11D724C3Q40187956-D564A5FD-226F-4B4F-81C0-6DD42FE4A09BQ41089558-FD6B0B06-746E-4C97-AA24-6BC6E7810C3DQ41690704-68b81fd4-4d06-5aaa-c73b-b68b8e7a45f2Q41789192-D10BF3DD-F9B2-40D5-9B1E-ECCAE18FC988Q42247868-5AB629CD-C52E-448C-8653-6D8B1824B7F1Q42340202-3B42FFD7-BC08-4F9B-B04B-86EBB30A19E7Q42785459-F5E206F4-4A20-4F22-B12F-AF3A489A48C0Q42808305-5172378C-988E-45F3-9E29-A1B77AB64D4BQ42884402-32797484-48CD-4E33-AE55-F9C8393CC9B1Q51125775-D4690756-D307-43BD-9696-B32FF6A1A63EQ53940121-9C0C9451-4F4A-420A-8DD9-D9CDEC839983Q54580338-23F3D627-AEC8-4514-9DE9-838DB71071CCQ55098275-F545227F-9816-4F83-B146-13A1EA5B2AD5Q55154238-F1D6C1D6-1D84-47D8-934C-69F0F165DBD6Q56850386-A7154E04-02B3-4A2C-AD22-1ADF51356181Q56855809-6B8CB13A-6A93-4FA6-87B6-F3CF8981BA71Q56953212-1DC20303-7E8D-4617-B9C4-52BA5339C944Q56953212-D0635EF8-D958-4E89-9301-3F6CC1301CFDQ56985516-311BC5C9-44C9-4750-9192-370030EDF795Q57434196-3319946C-CCC1-4432-B404-BA2A8C90E288Q57450360-BD559EF6-A044-42FF-9270-48AA1D5B6C3DQ57556195-70B4B6F6-54B7-4EE5-AC41-9992BF0A188EQ57567358-88CEFF0B-3279-4AE0-B731-CB94C3B8D198Q58147814-0A5BA6A8-E2F6-41F2-9536-69C9F40FE279Q58809399-4F4FDDC8-3C88-45CD-8431-C12D37B3448FQ59677883-473F8907-295B-4584-A689-6B2CD514F9C1Q59688531-1A0FD30E-6759-4FE8-9D80-84CE588BA37AQ59694720-23069135-C1F0-4AB9-AB1E-7B0B32B7CDCEQ59822526-CA9902DC-852E-4210-8EAC-0CF533359D55Q60310692-1E984D54-2FCC-4E01-BD05-575B426975E0Q60527395-30C43144-4D94-47EF-8C75-9094FC5EE7FEQ60662565-EE3B21A6-A831-4B5B-A195-CECE3B029FCBQ61108318-5EDF9DAF-6203-4AE4-8972-91367E79D13EQ61159512-1C817D75-754E-4C18-8C66-0E8F96C91E59
P108
Q58407485-3FBF57FE-A8A3-4BF6-91CB-68F89C739A93Q58407861-8F2F9B4A-24F4-4B9F-A43E-5FD8CD687595Q58407874-1BB6B7D5-5DDC-4569-B9C3-E339FB8C6234Q58407878-FF039095-EA9B-476D-BC4B-04AC0FCF759EQ58844786-889CD685-44D6-4A5A-938B-15EBE6C494EFQ58844832-C16AFE28-5697-47DF-BFA3-8A09F99A594BQ58844962-F4FF2736-59CB-4C8F-97C5-AA5E2F93A419Q58845122-1D32DEA1-DA68-4D79-8DF3-8F4EF0AAFC4AQ58845627-801F202E-245E-4DFA-9714-3C4875DF920DQ58845885-439E750B-5C67-4815-89F8-B2B461F367DAQ58845987-BFD3481B-C853-4604-90E6-14F7FFA4220AQ58847243-E8A48A26-30D6-4C30-978F-7798EF1EAFB2Q58848707-19DD32F8-A745-40C2-88F3-9AC95345FA90Q58848851-5DF4D4A7-2787-42E6-ADCC-D1147CC09C5EQ58849141-18652E3E-4311-4316-8E6D-26A28A33D39FQ58849643-7903881F-7D90-4AA7-83DB-AA81AA50E801Q61864703-636DBDE4-1EAF-4D31-AB38-9707D43E3A58Q61864779-A17A9954-552C-4D34-BA54-B7A616BCDC90Q61865043-EB51A2D4-8447-4B63-BEE3-8CA295CEE7C7Q61907246-229F3C4C-DFB7-4E5C-A528-A0DCBC4A874CQ61909515-0E7C396F-A9E8-4273-86C0-32C9E6DC90F4Q61914368-69B42AE2-EDDB-4AB7-A2FB-6F1C2C3DD5F4Q61914413-1F758511-1002-4C7C-8605-8A8D665FC995Q61914917-1CA8DAEF-5A84-4D76-8603-35729AD564D6Q61915256-5CA9FB97-677C-4BE0-B15C-1005FE7D67E7Q61917597-48FDF5E5-0339-4961-9D66-22D290EAF700Q61917783-8220421D-34BA-4301-AC01-99EEAF8BAE39Q61917852-0386EC50-1EC9-4A22-9FF4-02F3FE0D38E0Q61918149-8DE9EA54-3312-4F61-8D27-A6B1CEB05144Q61921020-C33D4059-50A7-4967-922E-5674E95ED86FQ61921071-B82A11C2-9DD4-4494-B36A-C93EB44320E4Q61921083-9D380E4A-FAC9-410C-836E-9479347D3F15Q61921134-3D1D96C1-7AC2-4940-8F2E-61837FA543A5Q61921999-DDE97820-EC59-4D15-8133-08832751808BQ61922099-6F21BC1D-F659-4454-8085-79B0DD141E2FQ61924493-6492693D-7085-4F89-8633-FA545745847DQ61932952-E6C95990-7A80-48D4-A746-5D94AF744FE8Q61933567-A259714E-5BE3-4B9F-BD22-7B3304CBADEEQ61933599-9AB15D70-0C1D-4A51-B8C0-90CE083117A9Q61936011-0F48BC3C-2B15-42CB-A6D7-7C0051AEC01D
P6153
description
Krankenhaus
@de
griya sakit
@jv
hospital d'Estaos Xuníos
@ast
hospital in New York, United States
@en
hôpital
@fr
rumah sakik
@min
rumah sakit di Amerika Serikat
@id
rumoh sakét
@ace
ziekenhuis in de Verenigde Staten
@nl
בית חולים בארצות הברית
@he
name
Roswell Park Comprehensive Cancer Center
@en
Roswell Park Comprehensive Cancer Center
@eo
罗斯威尔公园癌症研究所
@zh
罗斯威尔公园癌症研究所
@zh-cn
罗斯威尔公园癌症研究所
@zh-hans
羅斯威爾公園癌症研究所
@zh-hant
type
label
Roswell Park Comprehensive Cancer Center
@en
Roswell Park Comprehensive Cancer Center
@eo
罗斯威尔公园癌症研究所
@zh
罗斯威尔公园癌症研究所
@zh-cn
罗斯威尔公园癌症研究所
@zh-hans
羅斯威爾公園癌症研究所
@zh-hant
altLabel
Roswell Park Cancer Institute
@en
prefLabel
Roswell Park Comprehensive Cancer Center
@en
Roswell Park Comprehensive Cancer Center
@eo
罗斯威尔公园癌症研究所
@zh
罗斯威尔公园癌症研究所
@zh-cn
罗斯威尔公园癌症研究所
@zh-hans
羅斯威爾公園癌症研究所
@zh-hant
P1566
P214
P244
P3153
P6366
P131
P1566
P213
0000 0001 2181 8635
P214
P2427
grid.240614.5
P244
no91010163
P3153
P3417
Roswell-Park-Cancer-Institute
P571
1898-01-01T00:00:00Z
P625
Point (-78.86498 42.89869)
P6366
1292894508
P6782
P7859
lccn-no91010163